Completed NA INTERVENTIONAL 4-arm NCT02094287

Placebo Effect in the Treatment of Atopic Dermatitis

Placebo Effect in Atopic Dermatitis - Increase the Pharmacological Effect of Itching Caused by Classical Conditioning and Expectancy Processes: A Randomized Controlled Trial

Sponsor: Margitta Worm

Conditions Atopic Dermatitis

Interventions conditioning dimetindene instruction

Updated 6 times since 2017 Last updated: Sep 17, 2015 Started: Sep 30, 2010 Primary completion: Nov 30, 2013 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02094287, this NA trial focuses on Atopic Dermatitis and remains completed. Sponsored by Margitta Worm, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Margitta Worm
University of Hamburg-Eppendorf

Data source: Charite University, Berlin, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany
• Hamburg, Germany